AIM
FLGT icon

Anchor Investment Management’s Fulgent Genetics FLGT Stock Holding History

Anchor Investment Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-74
Closed -$4.62K – 985
2022
Q1 		$4.62K Hold
74
– – ﹤0.01% 855
2021
Q4 		$7.44K Buy
+74
New +$6.5K ﹤0.01% 822

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Anchor Investment Management's FLGT Position: Q2 2022 in Review

Anchor Investment Management sold out of Fulgent Genetics (FLGT) in Q2 2022, closing a stake of 74 shares — an estimated $4.62K sold.

Anchor Investment Management first reported a position in FLGT in Q4 2021 and held it in 2 quarters. The position peaked at $7.44K in Q4 2021. 262 funds tracked by Wall St. Rank hold FLGT as of Q2 2022.

  • Anchor Investment Management reported no remaining Fulgent Genetics position as of Q2 2022 after selling out during the quarter.
  • Anchor Investment Management sold 74 Fulgent Genetics shares in Q2 2022, an estimated $4.62K.
  • Anchor Investment Management first reported a position in Fulgent Genetics in Q4 2021 and held it in 2 quarters.
  • Anchor Investment Management's Fulgent Genetics position peaked at $7.44K in Q4 2021.
  • 262 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2022.

Based on Anchor Investment Management's 13F filing for Q2 2022, filed 2 Jan 2024.